Prometheus Laboratories has announced a new method for detecting antibody levels in individual patients treated with infliximab, a biologic therapy that has been used to treat more than a million patients across a number of autoimmune diseases.
Read MoreCardioDx has raised $5 million in Series D funding from the GE Healthymagination Fund. The investment is part of a larger round, which a regulatory filing suggests could be worth upwards of $45.5 million ($34.5m sold so far).
Read MoreGeneNews Limited announced that it has been granted two new US patents based on the company’s core platform technology, the Sentinel Principle.
Read MoreExosome Diagnostics Inc announces that it has raised $20 million co-led by NGN Capital and Forbion Capital Partners to further develop and commercialize a series of next-generation body fluid based oncology diagnostics through its proprietary, exosome based technology platform.
Read More
Vaginitis testing at the CentraCare Health Plaza lab goes molecular with the BD Affirm VPIII.
Read More